Avai Bio reported net income of -$0.55M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.15M | 0.33M | 0.01M | 0.10M | 0.21M | 0.04M | 0.03M | 0.00M | 0.01M | 0.15M | 0.08M | 0.06M | 750.00 | 0.10M | ||||||||||||||||||||
| Gross Profit | -0.09M | 0.29M | -0.05M | 0.02M | 0.01M | -0.07M | 1.00 | |||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 0.00M | |||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.02M | -0.01M | ||||||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 0.10M | 0.19M | 0.05M | 0.04M | 0.07M | 0.04M | 0.09M | 0.36M | 0.37M | 0.99M | -0.30M | 0.25M | 0.42M | 0.26M | -0.18M | 0.21M | 0.27M | 0.19M | 0.19M | 0.18M | ||||||||||||||
| Other Operating ExpensesOther Opex | 0.06M | 0.15M | 0.01M | 0.00M | -0.01M | 0.01M | 0.05M | 0.01M | 0.03M | 0.60M | 0.26M | 0.20M | 0.17M | 0.14M | 0.27M | 0.11M | 0.32M | -0.10M | 0.24M | |||||||||||||||
| Operating ExpensesOpex | 0.13M | 0.21M | 0.07M | 0.06M | 0.09M | 0.05M | 0.12M | 0.41M | 0.39M | 1.01M | 0.30M | 0.52M | 0.62M | 0.43M | -0.04M | 0.49M | 0.39M | 0.51M | 0.09M | 0.42M | ||||||||||||||
| Operating IncomeOp. Inc | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | 0.41M | 0.40M | 1.01M | -3.95M | -0.53M | 0.62M | 0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| EBIT | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | 0.41M | 0.40M | 1.01M | -3.95M | -0.53M | 0.62M | 0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | ||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.01M | -0.01M | -0.01M | -0.02M | ||||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | -0.41M | -0.40M | -1.01M | -3.95M | -0.53M | -0.62M | -0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Profit After TaxPAT | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.58M | -0.41M | -0.40M | -1.01M | -3.95M | -0.53M | -0.63M | -0.45M | 0.46M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | 0.19M | 0.35M | -0.02M | 0.03M | 0.07M | 0.12M | 0.12M | 0.41M | 0.40M | 1.01M | 0.62M | 0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | -0.41M | -0.40M | -1.01M | -3.95M | -0.53M | -0.62M | -0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | ||||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | -0.41M | -0.40M | -1.01M | -3.95M | -0.53M | -0.62M | -0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | -0.41M | -0.40M | -1.01M | -3.95M | -0.53M | -0.62M | -0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | -0.41M | -0.40M | -1.01M | -3.95M | -0.53M | 0.62M | 0.45M | -2.75M | -0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.05 | 0.00 | 0.01 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| EPS (Diluted) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | -0.02 | -0.04 | -0.15 | -0.02 | 0.02 | 0.02 | -0.10 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | ||||||||||||||
| Shares Outstanding | 26.28M | 26.32M | 26.32M | 26.32M | 26.32M | 26.32M | 38.50M | 57.65M | 74.27M | 74.84M | 86.53M | 115.83M | 123.60M | 137.00M | 128.15M | 137.46M | 137.62M | 138.03M | 137.97M | 153.92M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | 26.28M | ||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 26.32M | 26.32M | 26.32M | 26.32M | 26.32M | 26.32M | 38.50M | 64.50M | 64.50M | 84.79M | 86.53M | 117.02M | 131.87M | 137.13M | 137.36M | 137.51M | 137.83M | 138.03M | 153.21M | 153.92M | ||||||||||||||
| EBITDA | 0.17M | 0.35M | 0.01M | 0.03M | 0.08M | 0.11M | -0.57M | 0.41M | 0.40M | 1.01M | -3.95M | -0.53M | 0.62M | 0.45M | -2.75M | 0.49M | -0.45M | -0.55M | -0.26M | -0.55M | ||||||||||||||
| Interest ExpensesInt Expense | 0.00M | -0.00M |